Rep. Fazio Urges Funds for Childhood Cancer

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 7
Volume 7
Issue 7

WASHINGTON--A leading House Democrat has urged his colleagues to approve the funds necessary to make a proposed National Environmental Childhood Cancer Registry a reality.

WASHINGTON--A leading House Democrat has urged his colleagues to approve the funds necessary to make a proposed National Environmental Childhood Cancer Registry a reality.

"I am very excited about this idea because the nation does not have a childhood cancer registry to quantify and evaluate child-specific risks of cancer," Rep. Vic Fazio (D-Calif) told a congressional briefing sponsored by the National Coalition for Cancer Research.

He noted that researchers have long studied environmental, chemical, physical, and biological agents for their possible role in childhood cancers. "However, these studies are limited by inadequate exposure data and sample sizes that just don’t pass scientific muster," the congressman said. "More data are needed, and a national registry for children’s cancer could be the most effective way to explore the potential causes of this disease in children."

The registry would be operated by the Agency for Toxic Substances and Disease Registry, part of the Department of Health and Human Services, in cooperation with HHS, the Environmental Protection Agency, state agencies, and community organizations. A House appropriations subcommittee is currently considering a budget request for $350,000 to implement the plan.

"This seems like a very small price tag for something that could have a major impact on how we understand, ultimately prevent, and treat childhood cancer in the future," Rep. Fazio said.

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content